{"entity":{"type":"insider","cik":"0001658369","url":"/insider/0001658369","json_url":"/insider/0001658369.json","name":"Shenouda Maged","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":16,"first":"2015-12-16","last":"2025-12-16","span_basis":"filed_date"},"name_variants":[{"name":"Shenouda Maged","source":"filing","n_filings":16,"first_seen":"2015-12-16","last_seen":"2025-12-16"}],"transactions":[{"id":4847195,"accession":"0001213900-25-121973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-121973","line_url":"/filing/0001213900-25-121973#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11665.0,"shares_display":"11,665","price_per_share":4.12,"price_display":"4.12","price_state":"stated","total_value":48059.8,"total_display":"48,059.80","total_whole":"48,060","shares_owned_after":800000.0,"shares_owned_after_display":"800,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider"},{"id":4032042,"accession":"0001213900-25-106836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-106836","line_url":"/filing/0001213900-25-106836#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":1100000.0,"total_display":"1,100,000.00","total_whole":"1,100,000","shares_owned_after":788335.0,"shares_owned_after_display":"788,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-06","scope":"insider"},{"id":4907241,"accession":"0001213900-25-046087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-25-046087","line_url":"/filing/0001213900-25-046087#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":0.5237,"price_display":"0.52","price_state":"stated","total_value":31422.0,"total_display":"31,422.00","total_whole":"31,422","shares_owned_after":288335.0,"shares_owned_after_display":"288,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-20","scope":"insider"},{"id":4907236,"accession":"0001213900-25-046087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-046087","line_url":"/filing/0001213900-25-046087#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":0.4854,"price_display":"0.49","price_state":"stated","total_value":43686.0,"total_display":"43,686.00","total_whole":"43,686","shares_owned_after":228335.0,"shares_owned_after_display":"228,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-20","scope":"insider"},{"id":4907231,"accession":"0001213900-25-046087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-046087","line_url":"/filing/0001213900-25-046087#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.442,"price_display":"0.44","price_state":"stated","total_value":22100.0,"total_display":"22,100.00","total_whole":"22,100","shares_owned_after":138335.0,"shares_owned_after_display":"138,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":2641988,"accession":"0001213900-24-077792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-077792","line_url":"/filing/0001213900-24-077792#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24120.0,"shares_display":"24,120","price_per_share":2.95,"price_display":"2.95","price_state":"stated","total_value":71154.0,"total_display":"71,154.00","total_whole":"71,154","shares_owned_after":88335.0,"shares_owned_after_display":"88,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-11","scope":"insider"},{"id":2641982,"accession":"0001213900-24-077792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-077792","line_url":"/filing/0001213900-24-077792#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21118.0,"shares_display":"21,118","price_per_share":2.73,"price_display":"2.73","price_state":"stated","total_value":57652.14,"total_display":"57,652.14","total_whole":"57,652","shares_owned_after":64215.0,"shares_owned_after_display":"64,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-11","scope":"insider"},{"id":2641978,"accession":"0001213900-24-077792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-077792","line_url":"/filing/0001213900-24-077792#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8194.0,"shares_display":"8,194","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":20894.7,"total_display":"20,894.70","total_whole":"20,895","shares_owned_after":43097.0,"shares_owned_after_display":"43,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider"},{"id":3171148,"accession":"0001213900-24-008559","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-008559","line_url":"/filing/0001213900-24-008559#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6875.0,"shares_display":"6,875","price_per_share":4.0645,"price_display":"4.06","price_state":"stated","total_value":27943.4375,"total_display":"27,943.44","total_whole":"27,943","shares_owned_after":34903.0,"shares_owned_after_display":"34,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-01-31","scope":"insider"},{"id":3171145,"accession":"0001213900-24-008559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-008559","line_url":"/filing/0001213900-24-008559#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.8882,"price_display":"3.89","price_state":"stated","total_value":58323.0,"total_display":"58,323.00","total_whole":"58,323","shares_owned_after":28028.0,"shares_owned_after_display":"28,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider"},{"id":3171138,"accession":"0001213900-24-008559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-008559","line_url":"/filing/0001213900-24-008559#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10800.0,"shares_display":"10,800","price_per_share":3.6528,"price_display":"3.65","price_state":"stated","total_value":39450.24,"total_display":"39,450.24","total_whole":"39,450","shares_owned_after":13028.0,"shares_owned_after_display":"13,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":5016615,"accession":"0001213900-21-014656","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-21-014656","line_url":"/filing/0001213900-21-014656#line-5","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2373.0,"shares_display":"2,373","price_per_share":35.1089,"price_display":"35.11","price_state":"stated","total_value":83313.4197,"total_display":"83,313.42","total_whole":"83,313","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-10","scope":"insider"},{"id":5016613,"accession":"0001213900-21-014656","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-014656","line_url":"/filing/0001213900-21-014656","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7527.0,"shares_display":"7,527","price_per_share":35.56439649262654,"price_display":"35.56","price_state":"stated","total_value":267693.2124,"total_display":"267,693.21","total_whole":"267,693","shares_owned_after":6401.0,"shares_owned_after_display":"6,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-10","scope":"insider","n_lines":2},{"id":5016608,"accession":"0001213900-21-014656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-014656","line_url":"/filing/0001213900-21-014656#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":12128.0,"shares_owned_after_display":"12,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-10","scope":"insider"},{"id":4387848,"accession":"0001213900-21-012169","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-012169","line_url":"/filing/0001213900-21-012169","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":34.176413333333336,"price_display":"34.18","price_state":"stated","total_value":102529.24,"total_display":"102,529.24","total_whole":"102,529","shares_owned_after":3628.0,"shares_owned_after_display":"3,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-26","scope":"insider","n_lines":2},{"id":5507744,"accession":"0001213900-21-009696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-009696","line_url":"/filing/0001213900-21-009696#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1428.0,"shares_display":"1,428","price_per_share":35.3936,"price_display":"35.39","price_state":"stated","total_value":50542.0608,"total_display":"50,542.06","total_whole":"50,542","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":5262505,"accession":"0001213900-21-008202","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-008202","line_url":"/filing/0001213900-21-008202#line-4","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2410.0,"shares_display":"2,410","price_per_share":35.1973,"price_display":"35.20","price_state":"stated","total_value":84825.493,"total_display":"84,825.49","total_whole":"84,825","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":5262502,"accession":"0001213900-21-008202","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-008202","line_url":"/filing/0001213900-21-008202#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5359.0,"shares_display":"5,359","price_per_share":35.2385,"price_display":"35.24","price_state":"stated","total_value":188843.1215,"total_display":"188,843.12","total_whole":"188,843","shares_owned_after":4638.0,"shares_owned_after_display":"4,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":5262498,"accession":"0001213900-21-008202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-008202","line_url":"/filing/0001213900-21-008202#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3603.0,"shares_display":"3,603","price_per_share":35.0379,"price_display":"35.04","price_state":"stated","total_value":126241.5537,"total_display":"126,241.55","total_whole":"126,242","shares_owned_after":9997.0,"shares_owned_after_display":"9,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5385519,"accession":"0001213900-21-006832","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-006832","line_url":"/filing/0001213900-21-006832#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":5385517,"accession":"0001213900-21-006832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-006832","line_url":"/filing/0001213900-21-006832#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":35.0432,"price_display":"35.04","price_state":"stated","total_value":108633.92,"total_display":"108,633.92","total_whole":"108,634","shares_owned_after":2328.0,"shares_owned_after_display":"2,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":5438242,"accession":"0001213900-21-005451","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-005451","line_url":"/filing/0001213900-21-005451","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.926,"price_display":"31.93","price_state":"stated","total_value":95778.0,"total_display":"95,778.00","total_whole":"95,778","shares_owned_after":3428.0,"shares_owned_after_display":"3,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-29","scope":"insider","n_lines":2},{"id":5349078,"accession":"0001213900-21-004478","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-21-004478","line_url":"/filing/0001213900-21-004478#line-5","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":607.0,"shares_display":"607","price_per_share":35.16,"price_display":"35.16","price_state":"stated","total_value":21342.12,"total_display":"21,342.12","total_whole":"21,342","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-26","scope":"insider"},{"id":5349073,"accession":"0001213900-21-004478","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-004478","line_url":"/filing/0001213900-21-004478#line-4","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1280.0,"shares_display":"1,280","price_per_share":35.27,"price_display":"35.27","price_state":"stated","total_value":45145.6,"total_display":"45,145.60","total_whole":"45,146","shares_owned_after":2835.0,"shares_owned_after_display":"2,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-26","scope":"insider"},{"id":5349068,"accession":"0001213900-21-004478","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-004478","line_url":"/filing/0001213900-21-004478","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2113.0,"shares_display":"2,113","price_per_share":35.55323710364411,"price_display":"35.55","price_state":"stated","total_value":75123.99,"total_display":"75,123.99","total_whole":"75,124","shares_owned_after":4524.0,"shares_owned_after_display":"4,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-26","scope":"insider","n_lines":2},{"id":8521277,"accession":"0001213900-19-020722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-020722","line_url":"/filing/0001213900-19-020722#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":978.0,"shares_display":"978","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":22494.0,"total_display":"22,494.00","total_whole":"22,494","shares_owned_after":2228.0,"shares_owned_after_display":"2,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-21","filed_date":"2019-10-21","scope":"insider"},{"id":8655698,"accession":"0001415889-19-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-19-000015","line_url":"/filing/0001415889-19-000015#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"AzurRx BioPharma, Inc.","issuer_ticker":"AZRX","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Director, Officer (CHIEF FINANCIAL OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.3107,"price_display":"1.31","price_state":"stated","total_value":26214.0,"total_display":"26,214.00","total_whole":"26,214","shares_owned_after":62500.0,"shares_owned_after_display":"62,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":8701480,"accession":"0001213900-15-009537","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-15-009537","line_url":"/filing/0001213900-15-009537","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.9858633333333335,"price_display":"2.99","price_state":"stated","total_value":8957.59,"total_display":"8,957.59","total_whole":"8,958","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider","n_lines":3},{"id":8794415,"accession":"0001213900-15-009518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-15-009518","line_url":"/filing/0001213900-15-009518#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658369","owner_name":"Shenouda Maged","owner_display_name":"Shenouda Maged","owner_url":"/insider/0001658369","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":5780.0,"total_display":"5,780.00","total_whole":"5,780","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001553643","name":"RELMADA THERAPEUTICS, INC.","url":"/issuer/0001553643","role":"Director, Officer (Chief Financial Officer)","n_filings":15,"first_seen":"2015-12-16","last_seen":"2025-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001604191","name":"AzurRx BioPharma, Inc.","url":"/issuer/0001604191","role":"Director, Officer (CHIEF FINANCIAL OFFICER)","n_filings":1,"first_seen":"2019-01-02","last_seen":"2019-01-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658369","retrieved_at":"2026-08-25T17:02:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}